We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TGA Plans to Auto-Approve Low-Risk Product Variations
TGA Plans to Auto-Approve Low-Risk Product Variations
The Australian Therapeutic Goods Administration issued an industry guidance proposing to quickly approve certain types of low-risk variations to registered medicines without requiring evaluation, allowing sponsors to implement the changes immediately.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor